Demo Data from EDBT 2026 / reviewers in the wild / expert
Sébastien Hergalant
dblp:122/8913
· DBLP profile ↗
1ranked-venue papers
0as first author
1since 2021 · last 2025
0000-0001-8456-7992ORCID · reported
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 1 · 1 since 2021
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 100% | |
| Network and information security
1 paper |
Security and privacy of machine learning · 100% |
Topics — the 2 heaviest of 2, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › single-cell analysis
single-cell transcriptomics |
0.9 | 1 | 2025 | adverSCarial: assessing the vulnerability of single-cell RNA-sequencing classifiers to adversarial attacks · Bioinform. 2025 |
Security and privacy of machine learning
adversarial attack |
0.9 | 1 | 2025 | adverSCarial: assessing the vulnerability of single-cell RNA-sequencing classifiers to adversarial attacks · Bioinform. 2025 |
Methods — techniques the papers use, named apart from their topics
adversarial attack simulation · 1.7
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2025 | adverSCarial: assessing the vulnerability of single-cell RNA-sequencing classifiers to adversarial attacksabstractMOTIVATION: Several machine learning (ML) algorithms dedicated to the detection of healthy and diseased cell types from single-cell RNA sequencing (scRNA-seq) data have been proposed for biomedical purposes. This raises concerns about their vulnerability to adversarial attacks, exploiting threats causing malicious alterations of the classifiers' output with defective and well-crafted input. RESULTS: With adverSCarial, adversarial attacks of single-cell transcriptomic data can easily be simulated in a range of ways, from expanded but undetectable modifications to aggressive and targeted ones, enabling vulnerability assessment of scRNA-seq classifiers to variations of gene expression, whether technical, biological, or intentional. We exemplify the usefulness and performance with a panel of attack modes proposed in adverSCarial by assessing the robustness of five scRNA-seq classifiers, each belonging to a distinct class of ML algorithm, and explore the potential unlocked by exposing their inner workings and sensitivities on four different datasets. These analyses can guide the development of more reliable models, with improved interpretability, usable in biomedical research and future clinical applications. AVAILABILITY AND IMPLEMENTATION: adverSCarial is a freely available R package accessible from Bioconductor: https://bioconductor.org/packages/adverSCarial/ or https://doi.org/10.18129/B9.bioc.adverSCarial. A development version is available at https://github.com/GhislainFievet/adverSCarial. Ghislain Fiévet, Julien Broséus, David Meyre, Sébastien Hergalant |
Bioinform. | 4 |